N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study. (Q44907427)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study. |
scientific article |
Statements
N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study (English)
Mehdi Farokhnia
Forod Adinehfar
Seyed-Mohammad-Reza Hosseini
Habibeh Yekehtaz
Mina Tabrizi
Farzin Rezaei
Seyed-Mohammad-Hossein Sadeghi
Marzieh Moghadam
Omid Mirshafiee
1 November 2013